In mice with cancer, giving them creatine at doses similar to what humans take causes more cancer spread (metastasis) and shorter survival times.
Comparable evidence sits on both sides — science is divided.
Video analysis · Dr. William Wallace
The evidence on creatine and cancer is mixed, with some studies suggesting it may help cancer spread in mice, while others show it boosts anti-tumor immunity; human trials have not found harm.
Our research found a mix of supporting and contradicting evidence, with some claims strongly supported by animal and in vitro studies (pro scores up to 48) but others lacking human data (pro scores below 10). The overall picture is not clear-cut, and the video's title may overstate the risk for healthy individuals.
Our breakdown of the video
10 claims from the video, each with how well the evidence supports or refutes it.
Comparable evidence sits on both sides — science is divided.
The evidence supports this claim, but it is not high-grade.
The evidence supports this claim, but it is not high-grade.
Not enough evidence on either side yet.
The evidence supports this claim, but it is not high-grade.
The evidence supports this claim, but it is not high-grade.
The evidence supports this claim, but it is not high-grade.
The evidence supports this claim, but it is not high-grade.
The evidence supports this claim, but it is not high-grade.
Not enough evidence on either side yet.
Key takeaways
Based on the video transcript only without verifying against science.
What's valid: Creatine is a fuel that cells use for energy. Cancer cells and immune cells both use it.
What's off: The scary study only showed cancer spread in mice, not in humans. Human data only showed a change in platelets, not actual cancer.
Most interesting: The same molecule can both help cancer spread and help the body fight it, depending on which cell uses it.
Bottom line: For healthy people taking creatine, there's no reason to stop. Even cancer patients in a study didn't get worse.
Detailed report
The same claims written out: what the video argues, what to check before acting on it, and how to apply it.
Creatine's dual role: fuels both cancer spread and immune defense, with no human harm shown yet.
Original: A New Study Just Linked Creatine To Cancer
In short
The evidence on creatine and cancer is mixed, with some studies suggesting it may help cancer spread in mice, while others show it boosts anti-tumor immunity; human trials have not found harm.
Overview
The new study found that creatine supplementation in mice increased cancer metastasis by making platelets more active, and human platelets showed similar changes. However, other studies show creatine boosts immune cells against cancer. For healthy people, there is no human evidence that creatine causes cancer; a randomized trial in cancer patients showed no harm.
Our research found a mix of supporting and contradicting evidence, with some claims strongly supported by animal and in vitro studies (pro scores up to 48) but others lacking human data (pro scores below 10). The overall picture is not clear-cut, and the video's title may overstate the risk for healthy individuals.
Two recent studies published within weeks of each other found opposite effects of creatine on cancer. One study (Xie et al., 2026, Nature Communications) showed that creatine supplementation in mice increased metastasis by activating platelets, which shield tumor cells in the bloodstream. Human platelets also showed similar activation after creatine intake. In contrast, a study from UCLA (Kang et al., 2026, iScience) and prior work (Di Biase et al., 2019; Samborska et al., 2022; Peng & Saito, 2023) demonstrated that creatine enhances the activity of dendritic cells, T cells, and macrophages, leading to tumor shrinkage. Multiple earlier studies (e.g., Loo et al., 2015; Papalazarou et al., 2020; Zhang et al., 2021) had linked the creatine pathway to cancer growth. Furthermore, experimental drugs blocking creatine metabolism have shown promise against leukemia, prostate cancer, and colon cancer. However, a randomized placebo-controlled trial by the Mayo Clinic (Jatoi et al., 2017) in over 260 cancer patients found no difference in survival between creatine and placebo groups. The creator concludes that creatine functions as a fuel that can be used by both cancer cells and immune cells, similar to glucose and protein, and that for healthy individuals, there is no evidence that creatine causes cancer.
Our research found a mix of supporting and contradicting evidence, with some claims strongly supported by animal and in vitro studies (pro scores up to 48) but others lacking human data (pro scores below 10). The overall picture is not clear-cut, and the video's title may overstate the risk for healthy individuals.
A balanced understanding that while creatine can fuel cancer spread (via platelets) in lab settings, it also fuels anti-tumor immunity, and human trials have not shown harm. For healthy individuals, no change in supplementation is warranted.
The video's own numbers and outcomes, as stated.
Scoring key
A high score for and a low score against. High-grade evidence backs the claim and little of weight argues with it, so it stands well supported.
Similar scores on both sides. Evidence of comparable grade sits for and against, so science is divided on the claim.
A high score against and a low score for. High-grade evidence argues with the claim and little backs it, so it stands well refuted.
A low score on both sides. Little evidence of any grade exists either way, so the claim cannot be judged either way.
A score is the GRADE of the best evidence on that side, not the quality of the work: meta-analyses and randomized human trials grade highest, observational studies lower, animal and laboratory studies lower still. Higher grade means that side of the evidence carries more weight in the verdict; a lower score is lower-grade evidence that says less. Every claim is scored on both sides, so a verdict always weighs evidence for and evidence against — never a single score. A lead that never reaches high grade reads as Weakly supported or Weakly refuted: the evidence leans one way, but it is not strong enough to settle the claim either way.